Brookfield Canada Office Properties Renews Normal Course Issuer Bid
Nov 10, 2016 13:00 pm UTC| Business
BROOKFIELD NEWS, Nov. 10, 2016 -- Brookfield Canada Office Properties (“BOX”) (TSX:BOX.UN) (NYSE:BOXC) announced today that the Toronto Stock Exchange accepted a notice filed by BOX of its intention to renew its prior...
North State Announces Quarterly Dividend
Nov 10, 2016 13:00 pm UTC| Business
HIGH POINT, N.C., Nov. 10, 2016 -- North State, a leading fiber optic network, cloud and IT services provider, announced today that the board of directors of North State declared a cash dividend of $1.30 per share on...
DomainAssets.com announces HH.com domain name for sale
Nov 10, 2016 13:00 pm UTC| Business
BOCA RATON, Fla., Nov. 10, 2016 -- DomainAssets.com, a domain name and intellectual property brokerage firm, announced today that it has been selected as the exclusive brokerage company representing HH.com....
XBiotech to Provide Third Quarter 2016 Business Update on November 15
Nov 10, 2016 13:00 pm UTC| Business
AUSTIN, Texas, Nov. 10, 2016 -- XBiotech Inc. (NASDAQ:XBIT), developer of True Human™ therapeutic antibodies, announced today that it will host a live conference call and webcast on Tuesday, November 15, 2016, at 8:30...
Celsion Corporation Reports Third Quarter 2016 Financial Results and Provides Business Update
Nov 10, 2016 13:00 pm UTC| Business
Meaningful Progress with the ThermoDox® OPTIMA Study and GEN-1 Immunotherapy Program, Including Highly Encouraging Data from Primary Liver and Ovarian Cancer Studies Company to Hold Conference Call Today, November 10,...
Clearfield Reports Fiscal Fourth Quarter and Full Year 2016 Results
Nov 10, 2016 13:00 pm UTC| Business
MINNEAPOLIS, Nov. 10, 2016 -- Clearfield, Inc. (NASDAQ:CLFD), the specialist in fiber management and connectivity platforms for communication service providers, reported results for the fiscal fourth quarter and year...
Nov 10, 2016 13:00 pm UTC| Business
WALTHAM, Mass., Nov. 10, 2016 -- Proteon Therapeutics, Inc. (Nasdaq:PRTO), a company developing novel, first-in-class therapeutics to address the medical needs of patients with kidney and vascular diseases, today...